Across TCGA pan-cancer cohorts, GOLGA8T RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated GOLGA8T data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GOLGA8T RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA8T expression acts as an unfavorable survival marker, although some lineages such as KIRP and LUAD show a favorable association.
LUSC, STAD, and KIRP are the cancer types where GOLGA8T RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.